Cargando…

Neuroprotection in Glaucoma: Old and New Promising Treatments

Glaucoma is a major global cause of blindness, but the molecular mechanisms responsible for the neurodegenerative damage are not clear. Undoubtedly, the high intraocular pressure (IOP) and the secondary ischemic and mechanical damage of the optic nerve have a crucial role in retinal ganglion cell (R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rusciano, Dario, Pezzino, Salvatore, Mutolo, Maria Giulia, Giannotti, Rossella, Librando, Aloisa, Pescosolido, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664381/ https://www.ncbi.nlm.nih.gov/pubmed/30723498 http://dx.doi.org/10.1155/2017/4320408

Ejemplares similares

Hypotensive Effect of Nanomicellar Formulation of Melatonin and Agomelatine in a Rat Model: Significance for Glaucoma Therapy
por: Dal Monte, Massimo, et al.
Publicado: (2020)

Biomolecular Modulation of Neurodegenerative Events during Ageing
por: Nebbioso, Marcella, et al.
Publicado: (2015)

Relationship between Corneal Temperature and Intraocular Pressure in Healthy Individuals: A Clinical Thermographic Analysis
por: Fabiani, Claudia, et al.
Publicado: (2016)

A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma
por: Dal Monte, Massimo, et al.
Publicado: (2020)

The promise of neuroprotection by dietary restriction in glaucoma
por: Russo, Rossella, et al.
Publicado: (2021)

New retinal imaging for the visualization and analysis of vitreoretinal interface (VRI) by short-wavelength scanning laser ophthalmoscope (swSLO)
por: Vingolo, Enzo Maria, et al.
Publicado: (2011)

The Mozart effect in biofeedback visual rehabilitation: a case report
por: Salvatore, Serena, et al.
Publicado: (2011)

Differential activity and clinical utility of latanoprost in glaucoma and ocular hypertension
por: Pacella, Fernanda, et al.
Publicado: (2012)

Role of Protease-Inhibitors in Ocular Diseases
por: Pescosolido, Nicola, et al.
Publicado: (2014)

Degenerative effects in rat eyes after experimental ocular hypertension
por: Scarsella, G., et al.
Publicado: (2012)

Sturge-Weber Syndrome Associated with Monolateral Ocular Melanocytosis, Iris Mammillations, and Diffuse Choroidal Haemangioma
por: Plateroti, Andrea Maria, et al.
Publicado: (2017)

Atropine Differentially Modulates ECM Production by Ocular Fibroblasts, and Its Ocular Surface Toxicity Is Blunted by Colostrum
por: Cristaldi, Martina, et al.
Publicado: (2020)

Effects of Topical Gabapentin on Ocular Pain and Tear Secretion
por: Cammalleri, Maurizio, et al.
Publicado: (2021)

Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma
por: Adornetto, Annagrazia, et al.
Publicado: (2020)

Microbiome Dysbiosis: A Pathological Mechanism at the Intersection of Obesity and Glaucoma
por: Pezzino, Salvatore, et al.
Publicado: (2023)

New perspectives of immunomodulation and neuroprotection in glaucoma
por: Skopiński, Piotr, et al.
Publicado: (2021)

Neuroprotection in glaucoma
por: Vasudevan, Sushil K, et al.
Publicado: (2011)

Neuroprotection in Glaucoma
por: Nilforushan, Naveed
Publicado: (2012)

Neuroprotection in Glaucoma
por: Doozandeh, Azadeh, et al.
Publicado: (2016)

Neuroprotection in glaucoma
por: Vishwaraj, C R, et al.
Publicado: (2022)

Gabapentin Attenuates Ocular Inflammation: In vitro and In vivo Studies
por: Anfuso, Carmelina D., et al.
Publicado: (2017)

Dietary Supplementation of Antioxidant Compounds Prevents Light-Induced Retinal Damage in a Rat Model
por: Amato, Rosario, et al.
Publicado: (2021)

The Relationships Between Vitamin K and Cognition: A Review of Current Evidence
por: Alisi, Ludovico, et al.
Publicado: (2019)

Neurodegeneration and Neuroprotection in Glaucoma
por: Gauthier, Angela C., et al.
Publicado: (2016)

Neuroprotective therapies for glaucoma
por: Song, Wei, et al.
Publicado: (2015)

Neuroprotection in glaucoma-electrophysiology
por: Lešták, Ján, et al.
Publicado: (2020)

Fascicular Visual Field Defects in Open-Angle Glaucoma: Evaluation with Microperimetry
por: Arrico, Loredana, et al.
Publicado: (2016)

Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
por: Russo, Rossella, et al.
Publicado: (2015)

Current perspective of neuroprotection and glaucoma
por: Tian, Kailin, et al.
Publicado: (2015)

Neuroprotective agents in the management of glaucoma
por: Nucci, C., et al.
Publicado: (2018)

Taking “The Promise” Seriously: Medical Sociology’s Role in Health, Illness, and Healing in a Time of Social Change
por: Pescosolido, Bernice A.
Publicado: (2010)

Evidence on neuroprotective properties of coenzyme Q10 in the treatment of glaucoma
por: Martucci, Alessio, et al.
Publicado: (2019)

Anesthetic Preconditioning as Endogenous Neuroprotection in Glaucoma
por: Chou, Tsung-Han, et al.
Publicado: (2018)

Niacinamide and Neuroprotection: The Glaucoma Holy Grail
por: Bhartiya, Shibal
Publicado: (2022)

A Coming of Age for Glaucoma Neuroprotection
por: Johnson, Thomas V.
Publicado: (2023)

Restored retinal physiology after administration of niacin with citicoline in a mouse model of hypertensive glaucoma
por: Melecchi, Alberto, et al.
Publicado: (2023)

New solutions for old challenges in glaucoma treatment: is taurine an option to consider?
por: Iezhitsa, Igor, et al.
Publicado: (2020)

The Promise of Neuroprotective Agents in Parkinson’s Disease
por: Seidl, Stacey E., et al.
Publicado: (2011)

Rho Kinase Inhibitors as a Neuroprotective Pharmacological Intervention for the Treatment of Glaucoma
por: Thomas, Nisha M, et al.
Publicado: (2022)

Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
por: Tribble, James R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ttaguo4i24ma0ruikkg7m09les